Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data

Larissa Schwarzkopf, Petra Menn, Reiner Leidl, Sonja Wunder, Hilmar Mehlig, Peter Marx, Elmar Graessel, Rolf Holle, Larissa Schwarzkopf, Petra Menn, Reiner Leidl, Sonja Wunder, Hilmar Mehlig, Peter Marx, Elmar Graessel, Rolf Holle

Abstract

Background: Demographic ageing is associated with an increasing number of dementia patients, who reportedly incur higher costs of care than individuals without dementia. Regarding Germany, evidence on these excess costs is scarce. Adopting a payer perspective, our study aimed to quantify the additional yearly expenditures per dementia patient for various health and long-term care services. Additionally, we sought to identify gender-specific cost patterns and to describe age-dependent cost profiles.

Methods: The analyses used 2006 claims data from the AOK Bavaria Statutory Health Insurance fund of 9,147 dementia patients and 29,741 age- and gender-matched control subjects. Cost predictions based on two-part regression models adjusted for age and gender and excess costs of dementia care refer to the difference in model-estimated means between both groups. Corresponding analyses were performed stratified for gender. Finally, a potentially non-linear association between age and costs was investigated within a generalized additive model.

Results: Yearly spending within the social security system was circa €12,300 per dementia patient and circa €4,000 per non-demented control subject. About two-thirds of the additional expenditure for dementia patients occurred in the long-term care sector. Within our study sample, male and female dementia patients incurred comparable total costs. However, women accounted for significantly lower health and significantly higher long-term care expenditures. Long-term care spending increased in older age, whereupon health care spending decreased. Thus, at more advanced ages, women incurred greater costs than men of the same age.

Conclusions: Dementia poses a substantial additional burden to the German social security system, with the long-term care sector being more seriously challenged than the health care sector. Our results suggest that female dementia patients need to be seen as a key target group for health services research in an ageing society. It seems clear that strategies enabling community-based care for this vulnerable population might contribute to lowering the financial burden caused by dementia. This would allow for the sustaining of comprehensive dementia care within the social security system.

Figures

Figure 1
Figure 1
Unadjusted mean expenditures per year for dementia patients and non-demented control subjects.
Figure 2
Figure 2
Age-dependent cost profiles for health care, long-term care and formal care.

References

    1. Dementia - The NICE-Scie Guideline on supporting people with dementia and their carers in health and social care. The British Psychological Society, The Royal College of Psychiatrists, London; 2007.
    1. Bickel H. Dementia in advanced age: estimating incidence and health care costs. Z Gerontol Geriatr. 2001;34(2):108–115. doi: 10.1007/s003910170074.
    1. Ziegler U, Doblhammer G. Prevalence and incidence of dementia in Germany–a study based on data from the public sick funds in 2002. Gesundheitswesen. 2009;71(5):281–290. doi: 10.1055/s-0028-1119384.
    1. Peters E, Pritzkuleit R, Beske F, Katalinic A. Demographic change and disease rates: a projection until 2050. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2010;53(5):417–426. doi: 10.1007/s00103-010-1050-y.
    1. Busse R, Riesberg A. Health Care Systems in Transition: Germany. , Copenhagen; 2004.
    1. Hallauer JF, Schons M, Smalaa A, Berger K. Costs of medical treatment of Alzheimer patients in Germany. Gesundheitsökonomie Qualitätsmanagement. 2000;5:73–79.
    1. von der Schulenburg J-M, Schulenburg I, Horn R. In: The health economics of dementia. Wimo A, Karlson G, Jönson B, Winblad B, editor. Wiley, Chichester; 1998. Cost of treatment and cost of care for alzheimer’s disease in Germany; pp. 217–230.
    1. Kiencke P, Daniel D, Grimm C, Rychlik R. Direct costs of Alzheimer’s disease in Germany. Eur J Health Econ. 2011;12(6):533–539. doi: 10.1007/s10198-010-0267-x.
    1. Kronborg Andersen C, Sogaard J, Hansen E, Kragh-Sorensen A, Hastrup L, Andersen J, Andersen K, Lolk A, Nielsen H, Kragh-Sorensen P. The cost of dementia in Denmark: the Odense Study. Dement Geriatr Cogn Disord. 1999;10(4):295–304. doi: 10.1159/000017135.
    1. Martin BC, Ricci JF, Kotzan JA, Lang K, Menzin J. The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord. 2000;14(3):151–159. doi: 10.1097/00002093-200007000-00006.
    1. Hill JW, Futterman R, Duttagupta S, Mastey V, Lloyd JR, Fillit H. Alzheimer’s disease and related dementias increase costs of comorbidities in managed Medicare. Neurology. 2002;58(1):62–70. doi: 10.1212/WNL.58.1.62.
    1. Scuvee-Moreau J, Kurz X, Dresse A. The economic impact of dementia in Belgium: results of the National Dementia Economic Study (NADES) Acta Neurol Belg. 2002;102(3):104–113.
    1. Zhao Y, Kuo T-C, Weir S, Kramer MS, Ash AS. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer’s. BMC Health Serv Res. 2008;8:108. doi: 10.1186/1472-6963-8-108.
    1. Leicht H, Heinrich S, Heider D, Bachmann C, Bickel H, van den Bussche H, Fuchs A, Luppa M, Maier W, Mosch E. et costs of dementia by disease stage. Acta Psychiat Scand. 2011;124(5):384–395. doi: 10.1111/j.1600-0447.2011.01741.x.
    1. Rothgang H, Iwansky S, Müller R, Sauer S, Unger R. Barmer GEK Pflegereport 2010. Asgard-Verlag, St. Augustin; 2010.
    1. Schubert I, Küpper-Nybelen J, Ihle P, Krappweis J. Utilization patterns of dementia patients in the light of statutory health insurance data. Z Arztl Fortbild Qualitatssich. 2007;101(1):7–13.
    1. Eisele M, van den Bussche H, Koller D, Wiese B, Kaduszkiewicz H, Maier W, Glaeske G, Steinmann S, Wegscheider K, Schön G. Utilization patterns of ambulatory medical care before and after the diagnosis of dementia in Germany–results of a case–control study. Dement Geriatr Cogn Disord. 2010;29(6):475–483. doi: 10.1159/000310350.
    1. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Heal Econ. 2005;24(3):465–488. doi: 10.1016/j.jhealeco.2004.09.011.
    1. Le Cook B, McGuire TG, Lock K, Zaslavsky AM. Comparing methods of racial and ethnic disparities measurement across different settings of mental health care. Heal Serv Res. 2010;45(3):825–847. doi: 10.1111/j.1475-6773.2010.01100.x.
    1. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford University Press, Oxford; 2007.
    1. Akobundu E, Ju J, Blatt L, Mullins CD. Cost-of-illness studies: a review of current methods. PharmacoEconomics. 2006;24(9):869–890. doi: 10.2165/00019053-200624090-00005.
    1. Schäfer I, von Leitner E-C, Schön G, Koller D, Hansen H, Kolonko T, Kaduszkiewicz H, Wegscheider K, Glaeske G, van den Bussche H. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One. 2010;5(12):e15941. doi: 10.1371/journal.pone.0015941.
    1. Hunger M, Thorand B, Schunk M, Doring A, Menn P, Peters A, Holle R. Multimorbidity and health-related quality of life in the older population: results from the German KORA-Age study. Health Qual Life Outcomes. 2011;9(1):53. doi: 10.1186/1477-7525-9-53.
    1. Bird CE, Shugarman LR, Lynn J. Age and gender differences in health care utilization and spending for medicare beneficiaries in their last years of life. J Palliat Med. 2002;5(5):705–712. doi: 10.1089/109662102320880525.
    1. Cameron KA, Song J, Manheim LM, Dunlop DD. Gender disparities in health and healthcare use among older adults. J Women’s Health. 2010;19(9):1643–1650. doi: 10.1089/jwh.2009.1701.
    1. Werblow A, Felder S, Zweifel P. Population ageing and health care expenditure: a school of ‘red herrings’? Heal Econ. 2007;16(10):1109–1126. doi: 10.1002/hec.1213.
    1. Löppönen MK, Isoaho RE, Raiha IJ, Vahlberg TJ, Loikas SM, Takala TI, Puolijoki H, Irjala KM, Kivela S-L. Undiagnosed diseases in patients with dementia-a potential target group for intervention. Dement Geriatr Cogn Disord. 2004;18(3–4):321–329.
    1. Sanderson M, Wang J, Davis DR, Lane MJ, Cornman CB, Fadden MK. Co-morbidity associated with dementia. Am J Alzheimers Dis Other Demen. 2002;17(2):73–78. doi: 10.1177/153331750201700210.
    1. Bynum JP, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc. 2004;52(2):187–194. doi: 10.1111/j.1532-5415.2004.52054.x.
    1. Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M. Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer’s Disease Cooperative Study. Neurology. 1999;52(4):714–718. doi: 10.1212/WNL.52.4.714.
    1. Wilson RS, McCann JuJ, Li Y, Aggarwal NT, Gilley DW, Evans DA. Nursing home placement, day care use, and cognitive decline in Alzheimer’s disease. Am J Psychiatry. 2007;164(6):910–915. doi: 10.1176/appi.ajp.164.6.910.
    1. Aguero-Torres H, von Strauss E, Viitanen M, Winblad B, Fratiglioni L. Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol. 2001;54(8):795–801. doi: 10.1016/S0895-4356(00)00371-1.
    1. Schubert I, Köster I, Küpper-Nybelen J, Ihle P. Versorgungsforschung mit GKV-Routinedaten. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2008;51:1095–1105. doi: 10.1007/s00103-008-0644-0.
    1. Pressley JC, Trott C, Tang M, Durkin M, Stern Y. Dementia in community-dwelling elderly patients: a comparison of survey data, medicare claims, cognitive screening, reported symptoms, and activity limitations. J Clin Epidemiol. 2003;56(9):896–905. doi: 10.1016/S0895-4356(03)00133-1.
    1. Taylor DH, Ostbye T, Langa KM, Weir D, Plassman BL. The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. J Alzheimers Dis. 2009;17(4):807–815.
    1. Ostbye T, Taylor DH, Clipp EC, Scoyoc LV, Plassman BL. Identification of dementia: agreement among national survey data, medicare claims, and death certificates. Heal Serv Res. 2008;43(1 Pt 1):313–326.
    1. Newcomer RJ, Clay TH, Luxenberg JS, Miller RH. Misclassification and selection bias when identifying Alzheimer’s disease solely from Medicare claims records. J Am Geriatr Soc. 1999;47(2):215–219.
    1. Kronborg Andersen C, Lauridsen J, Andersen K, Kragh-Sorensen P. Cost of dementia: impact of disease progression estimated in longitudinal data. Scand J Public Health. 2003;31(2):119–125. doi: 10.1080/14034940210134059.
    1. Quentin W, Riedel-Heller SG, Luppa M, Rudolph A, König HH. Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. Acta Psychiatr Scand. 2009;121(4):243–259.
    1. de Meijer C, Koopmanschap M, Teresa BdU, van Doorslaer E. Determinants of long-term care spending: age, time to death or disability? J Heal Econ. 2011;30(2):425–438. doi: 10.1016/j.jhealeco.2010.12.010.
    1. Bhandari A, Wagner T. Self-reported utilization of health care services: improving measurement and accuracy. Med Care Res Rev. 2006;63(2):217–235. doi: 10.1177/1077558705285298.
    1. Schwarzkopf L, Menn P, Kunz S, Holle R, Lauterberg J, Marx P, Mehlig H, Wunder S, Leidl R, Donath C. et al.Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Value Health. 2011;14(6):827–835. doi: 10.1016/j.jval.2011.04.005.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅